INIST Corp.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
INIST Corp. - overview
Established
2000
Location
Yongin, Gyeonggi, South Korea
Primary Industry
Chemicals
About
Established in 2000 and based in Yongin, South Korea, INIST Corp. operates as a chemicals company that researches and develops generic raw pharmaceutical materials and incrementally modified drugs, and supplies them domestically and overseas. In December 2019, INIST Corp. raised KRW 9.
3 billion in venture funding from new investor Jacobson Pharma Corporation Limited. The company's key products for raw materials include anti-infectives, musculoskeletal disease drugs, and cardiovascular diseases, specifically Oseltamivir, Celecoxib, etc. The company also develops innovative drugs such as cardiac contrast agents and calcium channel blocker anticancer drugs.
Current Investors
Industrial Bank of Korea, Korea Development Bank, AJU IB Investment
Primary Industry
Chemicals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development, Medicinal Chemicals & Botanicals
Website
www.inistst.co.kr
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.